Analyze Diet

Topic:Muscarinic Receptors

Muscarinic receptors are a class of G protein-coupled receptors that are activated by the neurotransmitter acetylcholine. In horses, these receptors are distributed in various tissues, including the central nervous system, smooth muscles, and exocrine glands. They are involved in numerous physiological processes, such as modulation of cardiac function, regulation of gastrointestinal motility, and control of respiratory pathways. Muscarinic receptors are categorized into five subtypes (M1 to M5), each with distinct functions and tissue distributions. Research in equine medicine explores the role of muscarinic receptors in normal physiological processes and their involvement in pathophysiological conditions. This page compiles peer-reviewed research studies and scholarly articles that examine the distribution, function, and pharmacological targeting of muscarinic receptors in equine species.
Effects of acetylcholinesterase inhibition on quality of recovery from isoflurane-induced anesthesia in horses.
American journal of veterinary research    February 26, 2014   Volume 75, Issue 3 223-230 doi: 10.2460/ajvr.75.3.223
Wiese AJ, Brosnan RJ, Barter LS.To compare effects of 2 acetylcholinesterase inhibitors on recovery quality of horses anesthetized with isoflurane. Methods: 6 horses in phase 1, 7 horses in phase 2A, and 14 horses in phase 2B. Methods: The study comprised 3 phases (2 randomized, blinded crossover phases in horses undergoing orthopedic procedures and 1 prospective dose-determining phase). In phase 1, horses were anesthetized with isoflurane and received neostigmine or saline (0.9% NaCl) solution prior to anesthetic recovery. Phase 2A was a physostigmine dose-determining phase. In phase 2B, horses were anesthetized with isoflu...
Endothelial mechanisms underlying responses to acetylcholine in the horse deep dorsal penile vein.
European journal of pharmacology    May 17, 2005   Volume 515, Issue 1-3 150-159 doi: 10.1016/j.ejphar.2005.04.012
Martínez AC, Prieto D, Hernández M, Rivera L, Recio P, García-Sacristán A, Benedito S.This study evaluates the mechanisms underlying endothelium-dependent responses to acetylcholine in horse deep dorsal penile veins. Acetylcholine-induced relaxation was abolished by endothelium removal, the soluble guanylyl cyclase-inhibitor, and the nitric oxide (NO) synthase inhibitors. Acetylcholine-induced relaxation was inhibited by high K+ concentrations and blockade of large-conductance Ca(2+)-activated potassium (BK(Ca)) channels, and voltage-dependent potassium (K(v)) channels. Relaxations were unaffected by a small-conductance K(Ca) (SK(Ca)) channel blocker, or an ATP-sensitive potass...
Characterization of muscarinic receptor subtype mediating contraction and relaxation in equine coronary artery in vitro.
Journal of veterinary pharmacology and therapeutics    June 1, 1994   Volume 17, Issue 3 226-231 doi: 10.1111/j.1365-2885.1994.tb00237.x
Obi T, Kabeyama A, Nishio A.In coronary arterial rings isolated from horses, 10(-8)-10(-6) mol/l acetylcholine (ACh) induced concentration-dependent contractions which were potentiated by the removal of endothelium and by pretreatment with L-nitro-arginine (LNAG) or methylene blue (MB). Relatively lower concentrations of ACh (10(-14)-10(-8) mol/l) induced relaxation when the coronary rings were contracted by phenylephrine (PE). ACh-induced contractions in the coronary rings without endothelium were competitively inhibited by each muscarinic subtype selective antagonist in the following order of potency: 4-diphenylacetoxy...
Antagonism of pancuronium neuromuscular blockade in halothane-anesthetized ponies using neostigmine and edrophonium.
American journal of veterinary research    November 1, 1984   Volume 45, Issue 11 2276-2280 
Hildebrand SV, Howitt GA.Efficacy of neostigmine (0.04 mg/kg of body weight) and edrophonium (1 mg/kg), as antagonists for pancuronium neuromuscular blockade in halothane-anesthetized ponies, was evaluated. Neostigmine and edrophonium were satisfactory antagonists, with edrophonium having a significantly (P less than 0.01) more rapid onset of action than did neostigmine. Muscarinic activity of neostigmine and edrophonium was also evaluated. Neither antagonist was administered with atropine. Gastrointestinal effects, increased salivation, and increased airway secretions were minimal with edrophonium, but were marked af...